2024 | 2023 | 2022 | 2021 | 2020 | 2019
2024 Technical Bulletins
New Gram-Negative Bacillus Susceptibility Panels
View →
Outsourcing Blood Cultures for Fungi and Acid Fast Bacilli (AFB)
View →
Acceptable Fecal Occult Blood Collection Devices
View →
Procalcitonin Biomarker for Serious Infections – Update #1
View →
Reflex test algorithms for Hepatitis B and Hepatitis C
View →
Aerococcus Susceptibility to Antimicrobics
View →
Rapid PCR Testing for Mycobacterium tuberculosis
View →
Pyrazinamide (PZA) Testing for Mycobacterium tuberculosis
View →
Sexually Transmitted Infection Testing in Young Patients
View →
Legionella Testing by Urine Antigen & Legionella Culture
View →
Sending Out Mitochondrial M2 Antibody Testing
View →
Medical Device Recall: BIOFIRE FILMARRAY GI Panel
View →
2023 Technical Bulletins
Medical Device Recall: BIOFIRE FILMARRAY Pneumonia Panel
View →
No Longer Covered: Respiratory Panel & Stool GI Pathogen Panel
View →
HCV Panels simplify compliance with Public Health recommendations
View →
Discontinuation of DNA/RNA Shield Collection Media and DLS Central Testing for COVID-19 on ThermoFisher High-Throughput Platform
View →
Update to HSV Serology Testing and STI Panels
View →
Updated Interpretive Comments for QuantiFERON-TB Gold Plus
View →
Testing for Sexually Transmitted Infections - Update
View →
Testing for Sexually Transmitted Infections - Expansion
View →
New Testing for Carbapenemase Genes Improves Inpatient Management
View →
New Fecal Occult Blood Collection Devices
View →
SARS-CoV-2 EUA Fact Sheets for Providers
View →
2022 Technical Bulletins
Testing Support for 2022-2023 Respiratory Disease Season
View →
HIV Antigen/Antibody Screen Test Provides Analyte-Specific Results
View →
QuantiFeron IGRA Demonstrates Uncertainty Around the Cutoff
View →
Outsourcing Ova and Parasite Test for Intestinal Parasites
View →
Medicare Coverage Restriction for Combination Orders of Tumor Antigen CA 15-3 (TC 207) and CA 27.29 (TC 4659)
View →
Taxonomy Changes in the MALDI-TOF/MS Database
View →
Interpretation of SARS-CoV-2 (COVID-19) PCR Presumptive Positive
View →
2021 Technical Bulletins
Remove race from eGFR Calculation
View →
RAPIDPoint 500e Blood Gas Analyzer
View →
Procalcitonin Testing available in North Hawaii
View →
Suppression of Clostridioides difficile Result in Multiplex GI Panel
View →
Temporary Discontinuation of VerifyNow
View →
Update: Kappa and Lambda Light Chains, Free testing performed in house
View →
Fecal Lactoferrin Replacing WBC-Stool (Fecal Leukocytes) to Indicate Inflammation in the Bowel
View →
Discontinuation of Hemoccult Fecal Occult Blood Test
View →
Updated Albumin / Globulin Ratio Reference Range
View →
Tissue Oncology Testing is available in CARE*Link
View →
Oncology Testing Supports QMC Precision Medicine Program
View →
Discontinuation of In-house Hepatitis B envelope Ag and Ab Testing
View →
2020 Technical Bulletins
Updated Kappa and Lambda Light Chains, Free
View →
The VDRL Test Performed on CSF will Automatically Reflex to Provide a Titer
View →
Discontinuation of Streptozyme Testing
View →
Antimicrobic Susceptibility Interpretations
View →
Change in Ordering Practice for Outpatient Transfusions
View →
Tests Unavailable for Add-on Requests
View →
Preliminary bacterial identifications are now reported from positive blood culture by MALDI-TOF/MS
View →
Troponin T Generation 5 STAT Assay
View →
Rapid Multiplex Pneumonia Panel Now Available at Central
View →
2019 Technical Bulletins
Local testing for procalcitonin is available in Guam beginning December 17, 2019
View →
Update on Testing for Helicobacter Pylori Infections
View →
Rapid PCR replaces Antigen Testing for Influenza in Guam
View →
Availability of QuantiFERON-TB Gold Plus in Guam and Saipan
View →
Update for Urinalysis Result Reporting
View →
Quantitative CMV testing by qPCR available at DLS Central Laboratory
View →
Clostridioides (Clostridium) difficile screening now available at Queen’s Punchbowl and Queen’s West Oahu laboratories
View →
New Bood Culture Instruments and Bottles
View →
Updated Fluoroquinolone Susceptibility Interpretation
View →
Cefazolin Susceptibilities for Uncomplicated UTI Now Available
View →
Genotyping for HIV Drug Resistance now includes Integrase Inhibitors
View →
Routine and Special Circumstance use of Throat Culture
View →
Next Generation Hepatitis B Surface Antigen Assay
View →
Pneumococcus Testing by Rapid Antigen Compliments Laboratory Approach to Community-Acquired Pneumonia (CAP) and Meningitis
View →
Update to Protime INR reporting range
View →
Reflex test algorithms for Hepatitis B and Hepatitis C
View →